Dengsø, Kristine Elberg https://orcid.org/0000-0002-6486-4735
Tjørnhøj-Thomsen, Tine
Dalton, Susanne Oksbjerg
Christensen, Bo Marcel
Hillingsø, Jens
Thomsen, Thordis
Funding for this research was provided by:
Novo Nordisk Foundation (NNF15OC0017022, NNF16OC0022680)
Rigshospitalet (PSPE-22647-02)
Article History
Received: 22 March 2018
Accepted: 10 October 2018
First Online: 22 October 2018
Ethics approval and consent to participate
: The Central Science Ethics Committee in the Capital Region of Denmark evaluated the study protocol and deemed further formal approval unnecessary (Journal number 16020895). The study was approved by the Danish Data Protection Agency (I-suite number 04661) and performed in compliance with the Declaration of Helsinki []. The patients provided informed consent prior to participating. An effort from the interviewer (KD) was done in relation to ensuring confidentiality between the patients and interviewer. If questions about the interview or treatment arose after the interviews, the patients had access to an extra outpatient appointment. The first author (KD) informed eligible patients about the study, orally and in writing, allowing them sufficient time to reflect on participation. The patients were further informed about the possibility of withdrawing their consent at any time without this influencing their future treatment in any way.
: Not applicable.
: The authors declare they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.